This master lecture series focuses on dissemination of emerging clinical evidence and comprehensive oral and intravenous pharmacotherapy management practices in cancer care. The exponential growth of oncology therapies available, along with the increased utilization of multiple lines of therapies call for close oversight of rapidly expanding therapeutic options. In addition, advances in diagnostics expanding precision medicine modalities increasingly guide individualized therapy decisions. With vast and emerging scientific evidence on all fronts, it is essential for the clinical oncology care team to be empowered with cutting-edge education on evidenced-based treatment options for their patients.
